Cargando…

LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Radiotherapy, chemotherapy, autologous/allogeneic stem cell transplantation, and targeted drug therapy are currently available therapeutic options for multiple myeloma (MM), but the clinical outcome remains unsatisfactory owing to frequent occurrence of drug resistance. Anti apoptosis is one of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yafang, Zhang, Yu, Liu, Wenwen, Huang, Yan, Shen, Xianjuan, Jing, Rongrong, Pu, Jiang, Wang, Xudong, Ju, Shaoqing, Cong, Hui, Chen, Hongmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365572/ https://www.ncbi.nlm.nih.gov/pubmed/30728351 http://dx.doi.org/10.1038/s41419-018-1219-0

Ejemplares similares

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

PCAT‐1 promotes cell growth by sponging miR‐129 via MAP3K7/NF‐κB pathway in multiple myeloma
por: Shen, Xianjuan, et al.
Publicado: (2020)

Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib
por: Tang, Ju‐xian, et al.
Publicado: (2021)

Knockdown of long non-coding RNA PCAT-1 inhibits myeloma cell growth and drug resistance via p38 and JNK MAPK pathways
por: Shen, Xianjuan, et al.
Publicado: (2019)

Aberrant lncRNA Expression in Multiple Myeloma
por: Meng, Hui, et al.
Publicado: (2018)

The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma
por: Zhu, Bingying, et al.
Publicado: (2018)

Bortezomib-inducible long non-coding RNA myocardial infarction associated transcript is an oncogene in multiple myeloma that suppresses miR-29b
por: Fu, Yunfeng, et al.
Publicado: (2019)

Regulatory effects of lncRNAs and miRNAs on autophagy in malignant tumorigenesis
por: Yin, Qingqing, et al.
Publicado: (2018)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

LncRNA TUG1 Promotes Growth and Metastasis of Cholangiocarcinoma Cells by Inhibiting miR-29a
por: Hao, Wei Yuan, et al.
Publicado: (2020)

LncRNA AWPPH overexpression predicts the recurrence of periodontitis
por: Wang, Xiaofang, et al.
Publicado: (2019)

Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006)

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
por: Amodio, N, et al.
Publicado: (2012)

LncRNA2Target: a database for differentially expressed genes after lncRNA knockdown or overexpression
por: Jiang, Qinghua, et al.
Publicado: (2014)

LncRNA LINC00261 overexpression suppresses the growth and metastasis of lung cancer via regulating miR-1269a/FOXO1 axis
por: Guo, Caixia, et al.
Publicado: (2020)

The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890
por: Kang, Baojie, et al.
Publicado: (2021)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

LncRNA CCAL Promotes Angiogenesis Through Regulating the MiR-29b/ANGPTL4 Axis in Osteosarcoma
por: Chen, Shiyi, et al.
Publicado: (2020)

miR-29b and miR-198 overexpression in CD8(+) T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction
por: Gigante, Margherita, et al.
Publicado: (2016)

LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer
por: Ge, Chao, et al.
Publicado: (2020)

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms
por: Nguyen, Tri, et al.
Publicado: (2018)

lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma
por: Zhang, Shuhua, et al.
Publicado: (2021)

Retracted: The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890
por: Healthcare Engineering, Journal of
Publicado: (2023)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

An emerging potential therapeutic target for osteoporosis: LncRNA H19/miR-29a-3p axis
por: Li, Ziqi, et al.
Publicado: (2020)

LncRNA IPW inhibits growth of ductal carcinoma in situ by downregulating ID2 through miR-29c
por: Deshpande, Ravindra Pramod, et al.
Publicado: (2022)

Clinical outcomes of bortezomib-based therapy in myeloma
por: Djebbari, Faouzi, et al.
Publicado: (2018)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐363‐3p in gallbladder cancer
por: Wang, Shou‐Hua, et al.
Publicado: (2016)

Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway
por: Jiang, Bin, et al.
Publicado: (2022)

Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
por: Al-Odat, Omar S., et al.
Publicado: (2021)

Down-regulation of miR-203a by lncRNA PVT1 in multiple myeloma promotes cell proliferation
por: Yang, Man, et al.
Publicado: (2018)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

LncRNA CCAT1 is overexpressed in tuberculosis patients and predicts their survival
por: Ye, Taosheng, et al.
Publicado: (2021)

Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma
por: Guan, Guo-fang, et al.
Publicado: (2016)

Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93
por: Xu, Fengfeng, et al.
Publicado: (2018)

lncRNA TUG1 modulates proliferation, apoptosis, invasion, and angiogenesis via targeting miR-29b in trophoblast cells
por: Li, Qian, et al.
Publicado: (2019)

LncRNA GIHCG Promotes the Development of Esophageal Cancer by Modulating miR-29b-3p/ANO1 Axis
por: Zhao, Weifeng, et al.
Publicado: (2020)

LncRNA TUG1 contributes to ESCC progression via regulating miR‐148a‐3p/MCL‐1/Wnt/β‐catenin axis in vitro
por: Tang, Yin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1aeee2563kbq59dtehr6f22i6m